Select a Region North America

Optimizing the Performance of a PSP and Improving Outcomes For All Stakeholders

Patient Support Programs (PSP) have been proven to improve clinical and patient outcomes and help manage patient out-of-pocket cost and prescribed use. Particularly for specialty drugs, the services provided under the PSP umbrella not only help remove barriers to patient access, they provide healthcare providers (HCPs) with tools they can use to help patients better manage their disease. The challenge has been with ensuring a PSP is evolving and maturing in a way that aligns with patient and stakeholder needs as well as the product’s lifecycle.

Click here to download the white paper.

Author
John Chatas
Senior Consultant

John is a veteran healthcare and life sciences marketing and business development strategist who has been generating results on behalf of high-profile global enterprises for over 20 years. His experience includes engagements ranging in size from start-up…

Lee Ann brings with her more than 15 years of pharmaceutical and medical device experience working with companies such as Sanofi, Lash Group and UBC, Inc. Lee Ann uses her expertise to support the full life cycle…